Navigation Links
Arrow International Files and Mails Definitive Proxy Materials
Date:8/24/2007

ing day before the announcement of the Company's decision to explore strategic alternatives.

The Arrow Board of Directors unanimously recommends that shareholders vote "FOR" the adoption of the merger agreement, "FOR" the election of each Arrow nominee for director, and "FOR" the ratification of the appointment of PricewaterhouseCoopers LLP.

The McNeil Trust, owners of approximately 10% of Arrow common stock, has stated in a preliminary proxy filed with the Securities and Exchange Commission that it intends to vote "FOR" the proposal to adopt the Teleflex merger agreement.

The current Arrow Board of Directors initiated the process that led to the merger agreement with Teleflex, and while Arrow expects the merger to be consummated promptly following satisfaction or waiver of the conditions to the merger, it believes the current Board of Directors should be re-elected to manage any events which may arise following the 2007 Annual Meeting and prior to the consummation of the merger, which is expected to occur very shortly following the Annual Meeting.

Arrow is seeking, and the merger agreement requires, the adoption of the merger agreement by the affirmative vote of a majority of the votes cast by all Arrow shareholders entitled to vote at the Annual Meeting. The director nominees will be elected by a plurality of the votes cast at the Annual Meeting.

Shareholders are encouraged to read the Company's definitive proxy materials in their entirety as they provide, among other things, a detailed discussion of the process that led to the proposed merger and the reasons behind the Board of Directors' recommendation that shareholders vote "FOR" the adoption of the merger agreement.

The vote of Arrow shareholders is very important regardless of the number of shares of common stock they own. Whether or not shareholders are able to attend the Annual Meeting in person, they should complete, sign and date the WHITE proxy card and return it in th
'/>"/>

SOURCE Arrow International, Inc.
Copyright©2007 PR Newswire.
All rights reserved

Page: 1 2 3 4

Related biology technology :

1. Electroporation of Primary Bone Marrow Cells
2. Total marrow irradiation using TomoTherapy System performed at City of Hope
3. Criticare narrows loss, but sales drop after partner is bought
4. Broadlook narrows search for sales leads with software
5. Contest narrows to 52 business plans
6. Olympics of biotechnology has international flavor
7. Traffic data firm navigates international business
8. Catalyst International profit exceeds expectations
9. Lack of broadband hamstrings international videoconferencing
10. 30 days to success: Three simple steps to create your own international startup
11. TEKLYNX International announces new RFID software
Post Your Comments:
*Name:
*Comment:
*Email: